Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001516551-22-000030
Filing Date
2022-09-01
Accepted
2022-09-01 16:00:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A skyebioschedule14asoliciti.htm DEFA14A 20970
2 GRAPHIC skye-xlogoxxblacka.jpg GRAPHIC 208624
  Complete submission text file 0001516551-22-000030.txt   309201
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-55136 | Film No.: 221220945
SIC: 2834 Pharmaceutical Preparations